1. Home
  2. CHEK vs ATXG Comparison

CHEK vs ATXG Comparison

Compare CHEK & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • ATXG
  • Stock Information
  • Founded
  • CHEK 2004
  • ATXG 2014
  • Country
  • CHEK Israel
  • ATXG China
  • Employees
  • CHEK N/A
  • ATXG N/A
  • Industry
  • CHEK Medical Electronics
  • ATXG Professional Services
  • Sector
  • CHEK Health Care
  • ATXG Consumer Discretionary
  • Exchange
  • CHEK Nasdaq
  • ATXG Nasdaq
  • Market Cap
  • CHEK 3.9M
  • ATXG 3.8M
  • IPO Year
  • CHEK 2015
  • ATXG N/A
  • Fundamental
  • Price
  • CHEK $1.24
  • ATXG $0.47
  • Analyst Decision
  • CHEK
  • ATXG
  • Analyst Count
  • CHEK 0
  • ATXG 0
  • Target Price
  • CHEK N/A
  • ATXG N/A
  • AVG Volume (30 Days)
  • CHEK 98.8K
  • ATXG 400.6K
  • Earning Date
  • CHEK 11-28-2025
  • ATXG 11-14-2025
  • Dividend Yield
  • CHEK N/A
  • ATXG N/A
  • EPS Growth
  • CHEK N/A
  • ATXG N/A
  • EPS
  • CHEK N/A
  • ATXG N/A
  • Revenue
  • CHEK N/A
  • ATXG $4,310,835.00
  • Revenue This Year
  • CHEK N/A
  • ATXG N/A
  • Revenue Next Year
  • CHEK N/A
  • ATXG N/A
  • P/E Ratio
  • CHEK N/A
  • ATXG N/A
  • Revenue Growth
  • CHEK N/A
  • ATXG N/A
  • 52 Week Low
  • CHEK $0.56
  • ATXG $0.36
  • 52 Week High
  • CHEK $3.13
  • ATXG $1.86
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 34.47
  • ATXG 28.71
  • Support Level
  • CHEK $1.29
  • ATXG $0.45
  • Resistance Level
  • CHEK $1.35
  • ATXG $0.51
  • Average True Range (ATR)
  • CHEK 0.10
  • ATXG 0.10
  • MACD
  • CHEK -0.05
  • ATXG -0.03
  • Stochastic Oscillator
  • CHEK 1.75
  • ATXG 4.05

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: